In the prefrontal cortical lobe structures of human AD brains, a recent study demonstrates that a significant decrease in β-catenin protein levels is inversely associated with increased activation of GSK-3β,25 supporting the fact that GSK-3β activity is linked to Wnt/β-catenin signaling in AD brain. Here, GSK3B is linked to Alzheimer disease.